Skip to main content

Table 1 Patient and tumor characteristics

From: Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy

  

Survivors

Non-survivors

NA*

  

(n = 60)

(n = 23)

(n = 2)

Mean age (± SD)

years

51.1 ± 10.6

49.3 ± 8.3

46.4 ± 2.6

Mean tumor dimensions (mean ± SD)

mm

67.9 × 67.9 ± 18.0 × 19.8

78.6 × 77.3 ± 22.0 × 24.0

65.0 × 51.5 ± 7.1 × 26.2

NAC treatment

Epirubicin

25

8

-

 

Paclitaxel

23

5

2

 

Both1

12

10

-

Treatment

Partial response

40

11

1

response

Stable disease

20

12

1

AJCC

IIB

21

7

1

 

IIIA

25

11

1

 

IIIB

12

2

-

 

IV

2

3

-

ER status

+

41

7

2

 

-

19

15

-

 

unknown

-

1

-

PgR status

+

32

14

2

 

-

28

18

-

 

unknown

-

1

-

Nodes

+

32

14

1

 

-

28

9

1

Metastasis

+

2

2

0

 

-

58

21

2

  1. *NA, not applicable--One patient without following up and one patient dead by other causes; AJCC, American Joint Committee on Cancer; Both1, sequential treatment with Epirubicin and Paclitaxel
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us